Harvard Business School professor Amy Edmonson suggests that some of the best led teams may make more mistakes while they learn new ways of doing things. "When managers don't explicity recognize this reality, then the here and now appearance of high performance will seem far more valuable and preferable than learning, with its messy, error-drive nature." Does this hold true for pharma manufacturing teams too? To read more click here.
